SHERWIN WILLIAMS CO (SHW) Form 8-K — Oct 27, 2026
Sherwin-Williams reported Q3 2026 net sales of $6.86 billion, up 7.9% year-over-year, with growth across all three segments helped by price increases and the Suvinil acquisition. Diluted EPS rose just 0.9% to $3.38 while net income fell 1.5% to $821.0 million, pressured by higher raw material and supply chain costs and increased interest expense. The company returned $749.0 million to shareholders in the quarter and narrowed full-year 2026 guidance to $10.92-$11.22 diluted EPS and $11.85-$12.15 adjusted diluted EPS, versus $10.26 and $11.43 in 2025.
Key figures
- Eps
- 3.38
- Revenue
- 6860000000
- Guidance
- FY2026 diluted EPS $10.92-$11.22; adjusted diluted EPS $11.85-$12.15; Q4 net sales up mid-single digit %; FY net sales up mid to high-single digit %
- Net Income
- 821000000
- Total Debt
- 11795100000
- Revenue Yoy
- 7.9%
- Cash Position
- 264200000
- Shares Outstanding
- 240700000
- Ebitda
- $1.39 billion (20.3% of net sales)
- Adjusted eps
- 3.63
- Cbg net sales
- 937400000
- Adjusted ebitda
- $1.40 billion (20.5% of net sales)
- Cash returned 9m
- $2.98 billion (dividends plus repurchases of 7.1 million shares)
- Same store sales psg
- 3.9%
- Net operating cash 9m
- $2.59 billion
- Remaining buyback authorization
- 22.5 million shares
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.